Table 1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

Puntos clave

• HER2 expression was found to have significant conditional probabilities in metastatic prostate and urothelial cancers, indicating treatment opportunities.
• The study highlights potential differences in HER2 expression levels across cancer types, which may influence therapeutic strategies.
• Assessment of HER2 expression was conducted through an index sample analysis, providing insights into therapy selection.
• The findings support the need for tailored HER2-targeted therapies, especially in metastatic prostate and urothelial cancer patients.